Chronic Kidney Disease Clinical Trial
Official title:
Enhancing Education Regarding Living Donor Transplant Among Kidney Transplant Candidates
Verified date | July 2014 |
Source | St. Barnabas Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
The primary purpose of this study is to test different methods by which kidney transplant
centers can educate potential transplant candidates about living donor kidney transplant
(LDKT).
The most effective ways to educate kidney transplant candidates about LDKT remain unclear.
The goal is to determine, among a diverse cohort of potential kidney transplant candidates,
whether a transplant center-based intervention will increase understanding of the
opportunities for and process, risks, and benefits of living kidney donation and LDKT. The
investigators hypothesize that kidney transplant candidates' understanding of living kidney
donation and LDKT will be increased by interventions implemented at the transplant center on
the day of transplant evaluation.
The investigators propose a single-center, 2-arm, cluster-randomized, controlled trial to
compare the effects of two educational strategies upon transplant candidates' understanding
of living kidney donation and LDKT:
1. Usual transplant education implemented by the transplant center, on the day of the
transplant evaluation (standard care); and
2. Intensive initial transplant education implemented on the day of the transplant
evaluation.
Intensive initial transplant education will utilize videos of living donors' experiences as
well as a session with a trained Transplant Educator, who will focus upon living donation
education. One week after the transplant evaluation day and 3 months later, the
investigators will assess transplant candidates' knowledge of LDKT (using questionnaires),
identify correlates of increased understanding of LDKT, and assess racial/ethnic differences
in the understanding of LDKT.
Status | Completed |
Enrollment | 500 |
Est. completion date | June 2013 |
Est. primary completion date | June 2013 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Appear for initial kidney transplant evaluation at Saint Barnabas Medical Center - 18 years of age or older - Able to provide informed consent - Able to speak, hear, and understand English Exclusion Criteria: |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
Country | Name | City | State |
---|---|---|---|
United States | Saint Barnabas Medical Center | Livingston | New Jersey |
Lead Sponsor | Collaborator |
---|---|
St. Barnabas Medical Center | Health Resources and Services Administration (HRSA), University of Medicine and Dentistry of New Jersey |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Knowledge and understanding of the opportunities for and process, risks, and benefits of living kidney donation and LDKT | Up to 1 week after the transplant education day | No | |
Secondary | Knowledge and understanding of the opportunities for and process, risks, and benefits of living kidney donation and LDKT | Three months after the transplant education day | No | |
Secondary | Attitudes, confidence, and opinions regarding living kidney donation and LDKT | (1) Up to 1 week after the transplant education day, and (2) Three months after the transplant education day | No | |
Secondary | Changes in knowledge/understanding and attitudes/confidence/opinions regarding living kidney donation and LDKT | (1) Up to 1 week after the transplant education day, and (2) Three months after the transplant education day, compared to prior to the transplant evaluation day (baseline) | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Terminated |
NCT04043026 -
The Effects of Renal Function and Atrial Fibrillation on Lipoproteins and Clot Structure/Function
|
||
Completed |
NCT05318014 -
Low-protein Formula Supplements in Chronic Kidney Disease
|
N/A | |
Active, not recruiting |
NCT06071065 -
Clinical Pharmacist Intervention on Medication Adherence and Clinical Outcomes in Chronic Kidney Disease Patients
|
N/A | |
Completed |
NCT02878317 -
Skin Autofluorescence as a Risk Marker in People Receiving Dialysis.
|
||
Not yet recruiting |
NCT06039254 -
Safety and Pharmacokinetics of HRS-1780 in Healthy Subjects and Subjects With Impaired Renal Function
|
Phase 1 | |
Recruiting |
NCT03160326 -
The QUALITY Vets Project: Muscle Quality and Kidney Disease
|
||
Completed |
NCT02888171 -
Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency
|
N/A | |
Completed |
NCT02875886 -
DD-study: Diet or Diuretics for Salt-sensitivity in Chronic Kidney Disease
|
Phase 4 | |
Withdrawn |
NCT02885545 -
The Strategy to Prevent Hemorrhage Associated With Anticoagulation in Renal Disease Management (STOP HARM) Trial
|
Phase 4 | |
Completed |
NCT02756520 -
Observational Study on CKD Treatment With a Ketosteril Supplemented Protein-restricted Diet (Keto-024-CNI)
|
||
Completed |
NCT02896309 -
The Effect of Correction of Metabolic Acidosis in CKD on Intrarenal RAS Activity
|
N/A | |
Completed |
NCT02836574 -
A Study of Renal Autologous Cell Therapy (REACT) in Type 2 Diabetics With Chronic Kidney Disease
|
Phase 2 | |
Active, not recruiting |
NCT02483039 -
Nephrologist Follow-up Versus Usual Care After an Acute Kidney Injury Hospitalization
|
N/A | |
Completed |
NCT02369549 -
Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease
|
Phase 3 | |
Completed |
NCT02992548 -
Effect of Pravastatin on Erythrocyte Membrane Fatty Acid Contents in Patients With Chronic Kidney Disease
|
Phase 4 | |
Terminated |
NCT02543177 -
Optimised Procedure in Patients With NSTEMI and CKD
|
N/A | |
Recruiting |
NCT02205944 -
Impact of Presurgical Exercise on Hemodialysis Fistula Outcomes
|
N/A | |
Active, not recruiting |
NCT02231138 -
Efficacy and Safety of Abelmoschus Manihot for Chronic Kidney Disease
|
Phase 4 |